Kidney disease after heart and lung transplantation

American Journal of Transplantation

Volumn 6, Issue 4, 2006, Pages 671-679

  Bloom, R D ^a   Doyle, A M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cyclosporin; Heart transplantation; Kidney disease; Lung transplantation; Tacrolimus

Indexed keywords

ACETYLCYSTEINE; ANTIHYPERTENSIVE AGENT; ATORVASTATIN; AZATHIOPRINE; BICARBONATE; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ERYTHROPOIETIN; EZETIMIBE; FENOFIBRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; IRON; MYCOPHENOLIC ACID; RAPAMYCIN; STEROID; TSUKUBAENOLIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCINEURIN;

ANEMIA; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIALYSIS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; KIDNEY DISEASE; KIDNEY INJURY; LUNG TRANSPLANTATION; NEPHROTOXICITY; PERITONEAL DIALYSIS; PERITONITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; ACUTE KIDNEY FAILURE; END STAGE RENAL DISEASE; GRAFT RECIPIENT; KIDNEY TRANSPLANTATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY;

ACUTE DISEASE; CALCINEURIN; CHRONIC DISEASE; HEART TRANSPLANTATION; HUMANS; KIDNEY DISEASES; LUNG TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 33644780091     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01248.x     Document Type: Review

References (81)

1. Greenberg A Thompson M Griffith B et al. Cyclosporine nephrotoxicity in cardiac allograft patients - a seven year follow-up Transplantation 1990 50 589 593
2. Pattison JM Petersen J Kuo P Valantine V Robbins RC Theodore J The incidence of renal failure in one hundred consecutive heart-lung transplant recipients Am J Kidney Dis 1995 26 643 648
3. Broekroelofs J Stegeman CA Navis G de Jong PE Prevention of renal function loss after non-renal solid organ transplantation - how can nephrologists help to keep the kidneys out of the line of fire? Nephrol Dial Transplant 1999 14 1841 1843
4. Wilkinson AH Cohen DJ Renal failure in the recipients of nonrenal solid organ transplants J Am Soc Nephrol 1999 10 1136 1144
5. Ishani A Erturk S Hertz MI Matas AJ Savik K Rosenberg ME Predictors of renal function following lung or heart-lung transplantation Kidney Int 2002 61 2228 2234
6. Ojo AO Held PJ Port FK et al. Chronic renal failure after transplantation of a nonrenal organ N Engl J Med 2003 349 931 940
7. Goldstein DJ Zuech N Sehgal V Weinberg AD Drusin R Cohen D Cyclosporine-associated end-stage nephropathy after cardiac transplantation: Incidence and progression Transplantation 1997 63 664 668
8. Myers BD Ross J Newton L Luetscher J Perlroth M Cyclosporine-associated chronic nephropathy N Engl J Med 1984 311 699 705
9. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative Am J Kidney Dis 2002 39 2 Suppl 2 S1 246
10. Lanese D Conger J Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles J Clin Invest 1993 91 2144 2149
11. Ruggenenti P Perico N Mosconi L et al. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion Kidney Int 1993 43 706 711
12. Scherrer U Vissing SF Morgan BJ et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation N Engl J Med 1990 323 693 699
13. Zaltzman JS Pei Y Maurer J Patterson A Cattran DC Cyclosporine nephrotoxicity in lung transplant recipients Transplantation 1992 54 875 878
14. Sehgal V Radhakrishnan J Appel GB Valeri A Cohen DJ Progressive renal insufficiency following cardiac transplantation: Cyclosporine, lipids, and hypertension Am J Kidney Dis 1995 26 193 201
15. Tinawi M Miller L Bastani B Renal function in cardiac transplant recipients: retrospective analysis of 133 consecutive patients in a single center Clin Transplant 1997 11 1 8
16. Broekroelofs J Navis GJ Stegeman CA et al Long-term renal outcome after lung transplantation is predicted by the 1-month postoperative renal function loss Transplantation 2000 69 1624 1628
17. Vossler MR Ni H Toy W Hershberger RE Pre-operative renal function predicts development of chronic renal insufficiency after orthotopic heart transplantation J Heart Lung Transplant 2002 21 874 881
18. Myers B Newton L Cyclosporine-Induced chronic nephropathy: an obliterative microvascular renal injury J Amer Soc Nephrol 1991 2 S45 S52
19. Gardner M Houghton D Andoh T Lindsley J Bennett W Clinically relevant doses and blood levels produce experimental cyclosporine nephrotoxicity when combined with nitric oxide inhibition Transplantation 1996 61 1506 1512
20. Binet I Wallnofer A Weber C Jones R Thiel G Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A Kidney Int 2000 57 224 231
21. Israni A Brozena S Pankewycz O Grossman R Bloom R Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant recipients Am J Kidney Dis 2002 39 E16-20
22. Klein IH Abrahams A van Ede T Hene RJ Koomans HA Ligtenberg G Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects Transplantation 2002 73 732 736
23. Pratschke J Neuhaus R Tullius S et al Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation Transplantation 1997 64 938 940
24. English RF Pophal SA Bacanu SA et al Long-term comparison of tacrolimus- and cyclosporine-induced nephrotoxicity in pediatric heart-transplant recipients Am J Transplant 2002 2 769 773
25. Shihab FS Cyclosporine nephropathy: Pathophysiology and clinical impact Semin Nephrol 1996 16 536 547
26. Bertani T Ferrazzi P Schieppati A et al. Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients Kidney Int 1991 40 243 250
27. Falkenhain ME Cosio FG Sedmak DD Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine Transplantation 1996 62 364 370
28. Griffiths MH Crowe AV Papadaki L et al. Cyclosporin nephrotoxicity in heart and lung transplant patients Qjm 1996 89 751 763
29. Langham RG Egan MK Dowling JP Gilbert RE Thomson NM Transforming growth factor-beta1 and tumor growth factor-beta-inducible gene-H3 in nonrenal transplant cyclosporine nephropathy Transplantation 2001 72 1826 1829
30. Jain S Mohamed MA Sandford R Furness PN Nicholson ML Talbot D Sequential protocol biopsies from renal transplant recipients show an increasing expression of active TGF beta Transpl Int 2002 15 630 634
31. Trimarchi HM Truong LD Brennan S Gonzalez JM Suki WN FK506-associated thrombotic microangiopathy: Report of two cases and review of the literature Transplantation 1999 67 539 544
32. Roberts P Follette D Allen R Katznelson S Albertson T Cyclosporine A-associated thrombotic thrombocytopenic purpura following lung transplantation Transplant Proc 1998 30 1512 1513
33. Barone GW Gurley BJ Abul-Ezz SR Gokden N Sirolimus-induced thrombotic microangiopathy in a renal transplant recipient Am J Kidney Dis 2003 42 202 206
34. Go AS Chertow GM Fan D McCulloch CE Hsu CY Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 2004 351 1296 1305
35. Anavekar NS McMurray JJ Velazquez EJ et al Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction N Engl J Med 2004 351 1285 1295
36. Ventura HO Mehra MR Stapleton DD Smart FW Cyclosporine-induced hypertension in cardiac transplantation Med Clin North Am 1997 81 1347 1357
37. Taylor DO Barr ML Radovancevic B et al. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: Decreased hyperlipidemia and hypertension with tacrolimus J Heart Lung Transplant 1999 18 336 345
38. Peterson JC Adler S Burkart JM et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study Ann Intern Med 1995 123 754 762
39. Fried LF Orchard TJ Kasiske BL Effect of lipid reduction on the progression of renal disease: A meta-analysis Kidney Int 2001 59 260 269
40. End A Stift A Wieselthaler G et al Anemia and erythropoietin levels in lung transplant recipients Transplantation 1995 60 1245 1251
41. Frost AE Keller CA Anemia and erythropoietin levels in recipients of solid organ transplants. The Multi-Organ Transplant Group Transplantation 1993 56 1008 1011
42. Hunt BJ Amin S Halil O Yacoub M The prevalence, course, and characteristics of chronic anemia after heart and lung transplantation Transplantation 1992 53 1251 1256
43. Gleissner CA Murat A Schafer S et al. Reduced hemoglobin after heart transplantation is no independent risk factor for survival but is associated closely with impaired renal function Transplantation 2004 77 710 717
44. Dubrey SW Holt DW Banner N Measurement of mycophenolate mofetil plasma levels after heart transplantation and a potential side effect of high levels Ther Drug Monit 1999 21 325 326
45. Collins AJ Ma JZ Ebben J Impact of hematocrit on morbidity and mortality Semin Nephrol 2000 20 345 349
46. Tepel M van der Giet M Schwarzfeld C Laufer U Liermann D Zidek W Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine N Engl J Med 2000 343 180 184
47. Merten GJ Burgess WP Gray LV et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial JAMA 2004 291 2328 2334
48. Canver CC Heisey DM Nichols RD Acute renal failure requiring hemodialysis immediately after heart transplantation portends a poor outcome J Cardiovasc Surg (Torino) 2000 41 203 206
49. Snell GI Levvey BJ Chin W et al. Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment J Heart Lung Transplant 2002 21 540 546
50. Zakliczynski M Nozynski J Zakliczynska H Rozentryt P Zembala M Deterioration of renal function after replacement of cyclosporine with sirolimus in five patients with severe renal impairment late after heart transplantation Transplant Proc 2003 35 2331 2332
51. Trosch F Rothenburger M Schneider M et al First experience with rapamycin-based immunosuppression to improve kidney function after heart transplantation Thorac Cardiovasc Surg 2004 52 163 168
52. Groetzner J Meiser B Landwehr P et al. Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure Transplantation 2004 77 568 574
53. Groetzner J Kaczmarek I Landwehr P et al Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients Eur J Cardiothorac Surg 2004 25 333 341
54. De Meester JM Van Vlem B Walravens M et al Preservation of renal function after heart transplantation: Initial single-center experience with sirolimus Transplant Proc 2005 37 1835 1838
55. Zucker MJ Baran DA Arroyo LH et al De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: A one-year follow-up analysis Transplant Proc 2005 37 2231 2239
56. Aleksic I Baryalei M Busch T et al. Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine Transplantation 2000 69 1586 1590
57. Tedoriya T Keogh AM Kusano K et al Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil J Heart Lung Transplant 2002 21 976 982
58. Bunke M Ganzel B Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients J Heart Lung Transplant 1992 11 1194 1199
59. Brozena SC Johnson MR Ventura H et al. Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation. Results of a prospective, randomized multicenter trail J Am Coll Cardiol 1996 27 1707 1712
60. Elliott WJ Murphy MB Karp R Long-term preservation of renal function in hypertensive heart transplant recipients treated with enalapril and a diuretic J Heart Lung Transplant 1991 10 373 379
61. Lin J Valeri AM Markowitz GS D'Agati VD Cohen DJ Radhakrishnan J Angiotensin converting enzyme inhibition in chronic allograft nephropathy Transplantation 2002 73 783 788
62. Hetzel GR Hermsen D Hohlfeld T et al Effects of candesartan and perindopril on renal function, TGF-beta1 plasma levels and excretion of prostaglandins in stable renal allograft recipients Clin Nephrol 2002 57 296 302
63. Braith RW Mills RM Wilcox CS Mitchell MJ Hill JA Wood CE High dose angiotensin-converting enzyme inhibition prevents fluid volume expansion in heart transplant recipients J Am Coll Cardiol 2000 36 487 492
64. Schwietzer GK Hartmann A Kober G et al. Chronic angiotensin-converting enzyme inhibition may improve sodium excretion in cardiac transplant hypertension Transplantation 1995 59 999 1004
65. Minghelli G Seydoux C Goy JJ Burnier M Uricosuric effect of the angiotensin II receptor antagonist losartan in heart transplant recipients Transplantation 1998 66 268 271
66. Joint National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report JAMA 2003 289 2560 2572
67. American Heart Association, Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 2002 106 3143 3421
68. Kobashigawa JA Katznelson S Laks H et al. Effect of pravastatin on outcomes after cardiac transplantation N Engl J Med 1995 333 621 627
69. Christians U Jacobsen W Floren LC Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: Are the statins mechanistically similar? Pharmacol Ther 1998 80 1 34
70. Kasiske B Cosio FG Beto J et al. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: A report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative Am J Transplant 2004 4 Suppl 7 13 53
71. Lemahieu WP Hermann M Asberg A et al. Combined therapy with atorvastatin and calcineurin inhibitors: No interactions with tacrolimus Am J Transplant 2005 5 2236 2243
72. Devuyst O Goffin E Pirson Y van Ypersele de Strihou C Creatinine rise after fibrate therapy in renal graft recipients Lancet 1993 341 840
73. Lipscombe J Lewis GF Cattran D Bargman JM Deterioration in renal function associated with fibrate therapy Clin Nephrol 2001 55 39 44
74. Puthenparumpil JJ Keough-Ryan T Kiberd M Lawen J Kiberd BA Treatment of hypercholesterolemia with ezetimibe in the kidney transplant population Transplant Proc 2005 37 1033 1035
75. Koshman SL Lalonde LD Burton I Tymchak WJ Pearson GJ Supratherapeutic response to ezetimibe administered with cyclosporine Ann Pharmacother 2005 39 1561 1565
76. Anand IS Kuskowski MA Rector TS et al. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT Circulation 2005 112 1121 1127
77. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000 Am J Kidney Dis 2001 37 1 Suppl 1 S182 238
78. Meier-Kriesche HU Port FK Ojo AO et al Effect of waiting time on renal transplant outcome Kidney Int 2000 58 1311 1317
79. Mange K Marshall J Feldman H Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors N Engl J Med 2001 8 726 731
80. Bernardini J Piraino B Kormos RL Patient survival with renal replacement therapy in heart transplantation patients ASAIO J 1998 44 M546 548
81. Frimat L Villemot JP Cormier L et al Treatment of end-stage renal failure after heart transplantation Nephrol Dial Transplant 1998 13 2905 2908